期刊文献+

注射用英夫利西单抗治疗克罗恩病的疗效及护理体会 被引量:6

Efficacy and Nursing Experience of Infliximab Injection for the Treatment of Crohn's Disease Patients
下载PDF
导出
摘要 目的探讨克罗恩病采用注射用英夫利西单抗(类克)治疗的效果和护理方法。方法选择22例克罗恩病患者作为研究对象,回顾性分析其临床治疗资料。结果本组的22例患者中,16例显效、6例有效、0例无效,有效率为100%,并且无一例患者出现输液反应;同时,治疗前后的实验室指标和IBD-Q评分比较,差异具有统计学意义(P<0.05)。结论临床上给予克罗恩病患者类克治疗和护理,可以提高疗效。 Objective To explore the effect and nursing method of crohn's disease using infliximab injection(class gram)therapy.Methods 22 patients with crohn's disease were selected as the study subjects,and the clinical data were analyzed retrospectively.Results Among 22 patients in this group,16 patients were effective,6 patients were effective,no patient was invalid,and the effective rate was 100%,and none of the patients showed a transfusion reaction.At the same time,there was a statistically significant difference in laboratory index and IBD-Q score before and after treatment(P<0.05).Conclusion The clinical treatment and nursing of crohn's patients can improve the curative effect.
作者 袁虞芳 YUAN Yufang(Department of Gastroenterology,The Second Hospital Affiliated to Suzhou University,Suzhou Jiangsu 215000,China)
出处 《中国继续医学教育》 2018年第13期147-149,共3页 China Continuing Medical Education
关键词 克罗恩病 类克 护理 crohn's disease class gram nursing
  • 相关文献

参考文献7

二级参考文献69

  • 1李敏,乔爱珍.输注美罗华时不良反应的预防和护理[J].现代护理,2006,12(21):2036-2036. 被引量:16
  • 2Travis SPL, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn' s disease: current management. Gut, 2006, 55(suppl 1) : i16-i35.
  • 3Hanauer SB, Korelitz Bl, Rutgeerts P, et al. Postoperative maintenance of Crohn ' s disease remission with 6-mercaptopu fine, mesalamine, or placebo: a 2-year trial. Gastroenterology, 2004, 127:723- 729.
  • 4Ruemmele FM. lmmunomodulatlon with methotrexate: under used and undervalued? Dig Dis, 2009, 27:312- 314.
  • 5Wenzl HH, Hinterieitner TA, Aichbichler BW, et al. Myco phenolate mofetil for Crohn's disease; short tern, efficacy and long term outcome. Aliment Pharmacol Ther. 2004, 19: 427- 434.
  • 6Akobeng AK, Zachos M. Tumor necrosis factor alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst Rev, 2004, 1: CD003574.
  • 7Cornillie F, Shealy D, D'Haens G, et al. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther, 2001, 15:463 -473.
  • 8Sands BE, Anderson FH, Bernstein CN, et al. lnfliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med, 2004, 26:876- 885.
  • 9Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology, 2005, 128: 862- 869.
  • 10Siegel CA, Hur C, Korzenik JR, et al. Risks and benefits of in fliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol, 2006, 4:1017 -1024.

共引文献47

同被引文献55

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部